Live feed16:05:00·67dPRReleasevia QuantisnowMangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government StudyByQuantisnow·Wall Street's wire, on your screen.MGRX· Mangoceuticals Inc.Health Care
